전신성 홍반성 루푸스 환자에서 Bosentan 투여 후 발생한 스티븐스 존슨 증후군

참고문헌 (13)

1. "an epidemiologic study from West Germany", pp.839~42
2. "Dermatologic drug reactions", 24, pp.399~423 (2004)
3. "Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus", pp.665~6
4. "Drug eruption due to bosentan in a patient with systemic", 16, pp.188~190 (2006)
5. "Severe necrotizing leukocytoclastic vasculitis on a patient taking bosentan", 329, pp.430~ (2004)
6. "Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis", 333, pp.1600~1607 (1995)
7. "Severe cutaneous adverse reaction to drugs", pp.1272~85
8. "clinical findings and prognosis factors in 87 patients", pp.1160~5
9. "Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand", 162, pp.1515~1520 (2003)
10. "Immunopathology of toxic epidermal necrolysis an immunopathologic study of five cases", kerati and mo(cytes nuclear cells), pp.50~3, HLA-DR expression
11. "Expression of endothelin-1 in the lungs of patients with pulmonary hypertension", pp.1732~9
12. "A endothelin antagonism with bosentan: current status and future perspectives", 20, pp.1~18 (2002)
13. "Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study", 358, pp.1119~1123 (2001)

관련 논문AI추천